RankAlpha logo
Back to Rankings

URGN

UroGenD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
URGN vs peer average
30/100
URGN vs. peer average (D vs. C)
Grade spread
B 4 · C 2 · D 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

HRMY is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $2.13B

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerHRMYHarmony Biosciences
URGN
UroGen
HRMY
Harmony Biosciences
Grade
D
B
Momentum
96
58
Value
41
71
Sentiment
6
34
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs HRMY

URGN / HRMY
Grade Position
Below peers
URGN vs. peer average (D vs. C)
30/100
Momentum
96
URGN
Value
41
HRMY
Sentiment
6
HRMY

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs URGN
1
HRMY
Harmony Biosciences Holdings Inc Common
B
80/100
-2
2
SION
Sionna Therapeutics Inc Common
B
80/100
-2
3
VRDN
Viridian Therapeutics Inc Common
B
80/100
-2
4
MESO
Mesoblast Ltd ADR
D
40/100
Even
5
PVLA
Palvella Therapeutics Inc Common
C
60/100
-1
HRMY is the first peer returned for this comparison set.